From Monday, 4 November to Wednesday, 6 November, AmCham EU visited Copenhagen, Denmark to engage with Danish officials and discuss the latest life science developments. The delegates met with representatives from a range of government institutions, including the Ministry of Business, the Ministry of Industry and the Ministry of the Interior and Health. Top of mind throughout the visit was the potential revision of the Medical Devices Regulation, the Critical Medicines Act and the EU Pharmaceutical Legislation. With the EU being the world’s largest exporter of medicines in 2023, learn why reliable global life sciences supply chains are fundamental to resilient health systems.
Discussing healthcare developments in Copenhagen

Related items
:focal())
Industry calls for repeal of the SCIP database
AmCham EU has joined over 30 industry associations in calling on EU co-legislators to confirm the repeal of the Substances of Concern In articles as such or in complex objects (Products) (SCIP) database, as proposed in the Environmental Omnibus. SCIP costs companies around €225 million a year, yet its intended users, recyclers, barely use it. The Commission itself acknowledges that waste operators find the data unusable and most companies lack the resources to maintain millions of notifications. Repeal would remove a disproportionate reporting layer while keeping obligations for suppliers to inform customers about substances of very high concern. Any future approach should build on existing obligations, not add new ones.
Heading to Vilnius ahead of the upcoming Lithuanian Presidency
From Wednesday, 14 October to Friday, 16 October, AmCham EU visited Vilnius, Lithuania ahead of Lithuania’s upcoming Presidency of the Council of the European Union. The delegation met with Lithuanian policymakers and business representatives to exchange views on EU policy priorities, Europe’s competitiveness and the transatlantic partnership. The visit forms part of AmCham EU’s ongoing engagement with Member States ahead of their Presidency.
:focal())
Export controls fit for today's economy
The Dual-Use Regulation gives Europe a common framework for economic security, but divergent national implementation is weakening it. The same transaction can be assessed differently depending on the Member State, with guidance on cloud and software-as-a-service transfers remains unclear. Licensing processes, meanwhile, still assume a physical consignment rather than digital workflows, which sits poorly with how integrated global businesses operate. Companies bear the added cost and legal uncertainty, while the security benefit is limited. A single EU-wide approach to intangible transfers and closer alignment with the US and UK would make controls more predictable and let authorities focus on genuine risks. Read how the revision of the Dual-Use Regulation can deliver a harmonised and future-proof framework for Europe.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.